Clinical Trial

Global Patient Registry of Inherited Retinal Diseases

Study acronym: EYERD Registry
Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management.
Protocol Amendment History 1 change
critical Trial completed 2026-08-12
Trial Details
NCT Number NCT05957276
Lead Sponsor Janssen Research & Development, LLC
Conditions Inherited Retinal Diseases
Enrollment 887 participants
Start Date 2023-08-31
Primary Completion 2026-07-02 (estimated)
Study Completion 2026-07-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-11